Opening book details…
About this Medicine article
860PPhase II California cancer consortium trial of gemcitabine-eribulin combination (ge) in cisplatin ineligible patients (pts) with metastatic urothelial carcinoma (mUC): Efficacy report (NCI-9653; 1UM1CA186717, NO1-CM-2011-00038) by Sadeghi, S.; Groshen, S.; Parikh, R.A.; Mortazavi, A.; Dorff, T.; Hoimes, C.; Doyle, L.; Quinn, D.I.; Newman, E.; Lara, P. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Sadeghi, S.; Groshen, S.; Parikh, R.A.; Mortazavi, A.; Dorff, T.; Hoimes, C.; Doyle, L.; Quinn, D.I.; Newman, E.; Lara, P.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)